Delivery Order SPE2DB24D3013-SPE2DB26FFGBV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $7,796.69. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by November 5, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $3,977.47. This contract represents a firm fixed-price delivery order under a competitive, non-set-aside procurement and is scheduled for completion by July 25, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office and serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $9,102.67. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by October 30, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $5,943.55. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of May 7, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $1,368.56. This is a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Myrbetriq ER 50 mg tablets in a 90-count configuration, with a ceiling value of $6,187.69. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $18,945.55. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) at a ceiling value of $1,761.65. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 4, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $8,029.97. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is set for ultimate completion on August 13, 2025, with performance fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the...
- The Defense Logistics Agency awarded a $8,060.47 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 29, 2025, and represents a relatively short delivery timeline typical of pharmaceutical replenishment orders through the federal medical supply chain. The contract will be performed at AmerisourceBergen's corporate...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFGBVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Myrbetriq ER 50 mg tablets in a 90-tablet quantity, with a contract ceiling value of $8,599.88. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026 that supplies medications and medical supplies globally to military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements across multiple therapeutic domains through its extensive portfolio of brand-name and generic medications, vaccines, and medical devices. The contract supports critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 11/3/25 |